Lorten Tablet contains Loratadine 10 mg, a second-generation antihistamine indicated for the relief of symptoms associated with allergic conditions such as allergic rhinitis, chronic idiopathic urticaria, and other histamine-mediated allergic reactions. Loratadine selectively antagonizes peripheral H1 histamine receptors, thereby inhibiting the effects of endogenous histamine without causing significant sedation or anticholinergic side effects commonly associated with first-generation antihistamines. This non-sedating property makes Lorten suitable for daytime use, allowing patients to maintain normal activities without impairment. The tablet formulation ensures convenient oral administration, with rapid absorption and onset of action typically within 1 to 3 hours, providing symptomatic relief for up to 24 hours. Lorten is generally well tolerated; however, patients should be advised to adhere to the recommended dosage to minimize the risk of adverse effects such as headache, dry mouth, or gastrointestinal discomfort. It is contraindicated in individuals with known hypersensitivity to Loratadine or any of its excipients. Caution is advised when administering to patients with hepatic or renal impairment, and consultation with a healthcare professional is recommended before use during pregnancy or lactation. Lorten Tablet offers an effective and safe option for the management of allergic symptoms, improving patient quality of life.